Skip to content
10-Q

Quarterly Report

Kronos Bio, Inc.

0001741830-24-000067

← back to feed
Filed
Nov 13, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 8, 2024 60.34M sh
Shares Diluted Q3 2024 · Sep 30, 2024 60.31M sh
Shares Diluted Q3 2024 · Sep 30, 2024 59.98M sh
Shares Diluted Q3 2024 · Sep 30, 2023 58.15M sh
Shares Diluted Q3 2024 · Sep 30, 2023 57.57M sh
Capex Q3 2024 · Sep 30, 2024 $0
Capex Q3 2024 · Sep 30, 2023 $648K
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$52.6M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$53.56M
Short Term Investments Q3 2024 · Sep 30, 2024 $49.89M
Short Term Investments Q3 2024 · Dec 31, 2023 $108.67M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $74.96M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $64.33M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $57.6M
Stockholders Equity Q3 2024 · Sep 30, 2024 $111.13M
Stockholders Equity Q3 2024 · Jun 30, 2024 $123.15M
Stockholders Equity Q3 2024 · Mar 31, 2024 $136.97M
Stockholders Equity Q3 2024 · Dec 31, 2023 $159.08M
Stockholders Equity Q3 2024 · Sep 30, 2023 $178.62M
Stockholders Equity Q3 2024 · Jun 30, 2023 $203.34M
Stockholders Equity Q3 2024 · Mar 31, 2023 $225.61M
Stockholders Equity Q3 2024 · Dec 31, 2022 $244.5M
Current Liabilities Q3 2024 · Sep 30, 2024 $15.38M
Current Liabilities Q3 2024 · Dec 31, 2023 $24.7M
Total Liabilities Q3 2024 · Sep 30, 2024 $38.9M
Total Liabilities Q3 2024 · Dec 31, 2023 $54.2M
Current Assets Q3 2024 · Sep 30, 2024 $127.92M
Current Assets Q3 2024 · Dec 31, 2023 $178.78M
Total Assets Q3 2024 · Sep 30, 2024 $150.02M
Total Assets Q3 2024 · Dec 31, 2023 $213.28M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.23
Eps Diluted Q3 2024 · Sep 30, 2024 −$1.00
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.54
Eps Diluted Q3 2024 · Sep 30, 2023 −$1.52
Eps Basic Q3 2024 · Sep 30, 2024 −$0.23
Eps Basic Q3 2024 · Sep 30, 2024 −$1.00
Eps Basic Q3 2024 · Sep 30, 2023 −$0.54
Eps Basic Q3 2024 · Sep 30, 2023 −$1.52
Sga Expense Q3 2024 · Sep 30, 2024 $5.82M
Sga Expense Q3 2024 · Sep 30, 2024 $19.69M
Sga Expense Q3 2024 · Sep 30, 2023 $9.4M
Sga Expense restated Q3 2024 · Sep 30, 2023 $29.76M
Rd Expense Q3 2024 · Sep 30, 2024 $12.27M
Rd Expense Q3 2024 · Sep 30, 2024 $40.26M
Rd Expense Q3 2024 · Sep 30, 2023 $25.34M
Rd Expense restated Q3 2024 · Sep 30, 2023 $65.81M
Net Income Q3 2024 · Sep 30, 2024 −$14.11M
Net Income Q3 2024 · Sep 30, 2024 −$60.27M
Net Income Q3 2024 · Jun 30, 2024 −$16.2M
Net Income Q3 2024 · Mar 31, 2024 −$29.96M
Net Income Q3 2024 · Sep 30, 2023 −$31.37M
Net Income Q3 2024 · Sep 30, 2023 −$87.35M
Net Income Q3 2024 · Jun 30, 2023 −$29.74M
Net Income Q3 2024 · Mar 31, 2023 −$26.24M
Operating Income Q3 2024 · Sep 30, 2024 −$15.72M
Operating Income Q3 2024 · Sep 30, 2024 −$65.73M
Operating Income Q3 2024 · Sep 30, 2023 −$33.83M
Operating Income Q3 2024 · Sep 30, 2023 −$94.49M
Revenue Q3 2024 · Sep 30, 2024 $2.37M
Revenue Q3 2024 · Sep 30, 2024 $7.58M
Revenue Q3 2024 · Sep 30, 2023 $917K
Revenue Q3 2024 · Sep 30, 2023 $4M